Tag Archives: NEM

Hot Low Price Stocks To Watch Right Now

Leave a reply

L Brands, owner of Victoria’s Secret and Bath & Body Works, on Wednesday reported mixed results in the holiday quarter that sent shares of the company down more than 5 percent.

Same-store sales at its Victoria’s Secret brand have struggled to keep up with changing tastes and new competition, and fell 3 percent.

The brand, which was once known for its sexy bras, has lost out as women have switched to more comfortable bra styles and brands that seem more inclusive from the likes of American Eagle’s Aerie, Third Love, Lively and Adore Me. The $7.2 billion bra category is also seeing new competition from Target, which this spring plans to launch three new lines of lingerie and sleepwear.

Millennials, which comprise more than a third of the women’s intimate apparel market, spent a third of its bra dollars in 2018 on sports bras, according to retail trade group the NPD Group.

Hot Low Price Stocks To Watch Right Now: Tanzanian Royalty Exploration Corporation(TRX)

The Company was originally incorporated under the corporate name “424547 Alberta Ltd.” in the Province of Alberta on July 5, 1990, under the Business Corporations Act (Alberta). The name was changed to “Tan Range Exploration Corporation” on August 13, 1991. The name of the Company was again changed to “Tanzanian Royalty Exploration Corporation” on February 28, 2006. The Company is also registered in the Province of British Columbia as an extra-provincial company under the Business Corporations Act (British Columbia).

The principal executive office of the Company is located at Suite 404 – 1688 152nd Street, South Surrey, BC V4A 4N2, Canada, and its telephone number is (604) 536-7873.   Advisors’ Opinion:

  • [By Ethan Ryder]

    TRON (CURRENCY:TRX) traded down 0.8% against the dollar during the 24 hour period ending at 21:00 PM E.T. on February 26th. One TRON coin can currently be purchased for approximately $0.0242 or 0.00000630 BTC on major exchanges including Kucoin, Kryptono, Fatbtc and Hotbit. During the last seven days, TRON has traded 3.1% lower against the dollar. TRON has a total market capitalization of $1.61 billion and $151.03 million worth of TRON was traded on exchanges in the last day.

  • [By Joseph Griffin]

    TRON (CURRENCY:TRX) traded up 2.2% against the US dollar during the twenty-four hour period ending at 21:00 PM E.T. on August 23rd. One TRON coin can now be bought for approximately $0.0205 or 0.00000315 BTC on exchanges including Huobi, Koinex, OpenLedger DEX and Bithumb. TRON has a market capitalization of $1.35 billion and $80.96 million worth of TRON was traded on exchanges in the last 24 hours. In the last seven days, TRON has traded up 2.3% against the US dollar.

  • [By Logan Wallace]

    Tanzanian Royalty Exploration Co. (NYSEAMERICAN:TRX) (NYSEMKT:TRX) was the target of a significant decline in short interest during the month of May. As of May 15th, there was short interest totalling 3,876,222 shares, a decline of 0.6% from the April 30th total of 3,901,135 shares. Based on an average trading volume of 311,237 shares, the short-interest ratio is presently 12.5 days. Currently, 3.3% of the company’s shares are short sold.

Hot Low Price Stocks To Watch Right Now: Honeywell International Inc.(HON)

Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment provides turbine propulsion engines, auxiliary power units, environmental control and electric power systems, engine systems and accessories, avionic systems, aircraft lighting, inertial sensors, control products, space products and subsystems, and landing products for aircraft manufacturers, airlines, business and general aviation, military, space, and airport operations, as well as offers management and technical, logistics, aircraft wheels and brakes and repair, and overhaul services. The company?s Automation and Control Solutions segment provides environmental and combustion controls, and sensing controls; security and life safety products and services; scanning and mobility products; process automation products and solutions; and building solutions and services for homes, buildings, and industrial facilities. Its Specialty Materials segment prov ides resins and chemicals; hydrofluoric acid; fluorocarbons; fluorine specialties; nuclear services; performance chemicals; chemical processing sealants; fibers and composites; specialty films and additives; imaging and electronic chemicals; semiconductor materials and services; catalysts, adsorbents, and specialties; and renewable fuels and chemicals. It offers these products for refining, petrochemical, automotive, healthcare, agricultural, packaging, refrigeration, appliance, housing, semiconductor, wax, and adhesives segments. This segment also provides process technology and equipment for the petroleum refining, and petrochemical and gas processing industries. The company?s Transportation Systems segment provides charge-air systems; thermal systems; filters, spark plugs, electronic components, and car care products; and brake hard parts and other friction materials for passenger cars and commercial vehicles. The company was founded in 1920 and is headquartered in Morris Township, New Jersey.

Advisors’ Opinion:

  • [By Jim Robertson]

    By staying away, Cramer meant staying away from retail stock in general and instead favor stocks like Adobe (NASDAQ: ADBE) and Salesforce.com(NYSE: CRM)as they work to make sure customers enjoy their experience and remember to come back along with Honeywell (NYSE: HON) which sells robotics to Amazon.

  • [By Lee Samaha]

    Based on management’s guidance for 2019 and the underlying trends in its business, you can make a strong case for buying stock in Honeywell International (NYSE:HON). The questions are whether the company can hit its guidance in 2019, and where in the guidance range it could be.

Hot Low Price Stocks To Watch Right Now: CytomX Therapeutics, Inc.(CTMX)

CytomX Therapeutics, Inc., incorporated on October 16, 2010, is an oncology-focused biopharmaceutical company. The Company is engaged in the development of a class of antibody therapeutics based on its Probody technology platform. The Company uses its platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against a range of targets. The Company’s Probody therapeutics are designed to take advantage of the conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues. A Probody therapeutic consists of three components produced as a single protein by standard antibody production methodology: an active anti-cancer antibody, a mask for the antibody and a protease-cleavable linker. When a Probody therapeutic enters a tumor, it encounters proteases, which are enzymes that cleave proteins and are active primarily in the tumor microenvironment. The proteases in the tumor cleave the linker, releasing the mask and allowing the antibody to attack the tumor. The Company’s Probody candidates are designed to be produced as fully recombinant antibody prodrugs.

The Company’s Probody product candidate, CX-072, is directed against programmed death-ligand 1 (PD-L1). CX-072 is based on a monoclonal antibody targeting PD-L1. The Company focuses on investigating the clinical potential of its PD-L1 Probody therapeutic in a Phase I trial in indications where preliminary efficacy has already been demonstrated with other PD-L1 antibody products used as monotherapy, such as in melanoma, non-small cell lung cancer or bladder cancer.

The Company’s product candidate, CX-2009, is a Probody drug conjugate (PDC) directed against the target CD-166, which is expressed in multiple tumor types, including breast, lung, colorectal and prostate cancer. The CD-166 Probody, referred to as activated leukocyte cell adhesion molecule (ALCAM), is involved with cell adhesion and m! igration.. Its expression is linked to cancer stem cells and overall poor prognosis in cancers, such as colorectal cancer. CX-2009 consists of a Probody therapeutic targeting the CD-166 protein antigen coupled to a potent cytotoxic drug, DM4. The Company is conducting preclinical trials of CD-166 PDC.

The Company is pursuing the application of its Probody technology to a range of other product candidates. These include other product candidates directed against checkpoint pathways, and other PDC product candidates. The Company is advancing product candidates based on T-cell-recruiting bispecific antibodies. A bispecific antibody is a product that is engineered to simultaneously recognize two distinct antigens. The Company is engaged in developing a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) Probody therapeutic. CTLA-4 is an immune checkpoint involved in regulating T-cell activation. CTLA-4 antibodies lead to T-cell activation for a range of antigens, including tumor antigens and self-antigens.

The Company is developing a programmed cell death protein 1 (PD-1) Probody therapeutic as an additional approach to block the PD-L1/PD-1 pathway. PD-1 is the receptor for the PD-L1 ligand responsible for inhibiting T-cell activation. It is the target for various immuno-oncology products, including nivolumab and pembrolizumab for the treatment of melanoma. Transferrin receptor 1, also known as CD-71, is a protein that is used for iron uptake in dividing cells, is expressed at low levels in normal tissues and is overexpressed in tumor cells. The Company’s CD-71 PDC has demonstrated efficacy in lung and breast xenograft models. The Company is also conducting Integrin alpha-3 PDC program. Integrins are cell surface proteins that are responsible for cell-cell and cell-extracellular matrix interactions. Integrin alpha-3 (ITGA3) is expressed and prevalent in cancers, such as pancreatic, ovarian, and breast and it is associated with tumorigenesis and metastasis. The Company’s ITGA3 PDC h! as demonst! rated efficacy in a range of xenograft models.

The Company competes with AdaptImmune LLC, AstraZeneca PLC, BMS, GlaxoSmithKline plc, Idera Pharmaceuticals, Inc., Immune Design Corp, Merck & Co., Inc., NewLink Genetics Corporation, Novartis AG, Pfizer, Roche Holding Ltd, Sanofi SA, ImmunoGen, Seattle Genetics, Inc., Argos Therapeutics, Inc., Bellicum Pharmaceuticals, Inc., Biovest International, Inc., Bluebird bio, Inc., Celgene Corporation, Cellectis SA, ImmunoCellular Therapeutics, Ltd., Inovio Pharmaceuticals, Inc., Intrexon Corporation, Juno Therapeutics, Inc., Kite Pharma, Inc., NantKwest, Inc., Northwest Biotherapeutics, Inc. and Valeant Pharmaceuticals.

Advisors’ Opinion:

  • [By Motley Fool Transcription]

    CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q1 2019 Earnings Call May 9, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Chris Lange]

    CytomX Therapeutics Inc. (NASDAQ: CTMX) is presenting on a couple different topics: probody conjugate (CX-2009) treatment in patients with advanced solid tumors and probody drug conjugate targeting CD166 in preclinical antitumor activity. Wedbush has an Outperform rating with a price target of $25, implying upside of 123% from Fridays closing price of $11.22. The shares have a 52-week range of $10.91 to $35.00. The stock has a consensus price target of $29.20.

  • [By Stephan Byrd]

    Shares of CytomX Therapeutics Inc (NASDAQ:CTMX) have been given a consensus recommendation of “Buy” by the ten ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $38.33.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CytomX Therapeutics (CTMX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Low Price Stocks To Watch Right Now: Web.com Group, Inc.(WEB)

Web.com Group, Inc. provides Internet services to small businesses in North America, South America, and the United Kingdom. The company offers a range of Web services and products that enable small businesses to establish, maintain, promote, and optimize their online presence. It provides domain name registration, such as .com and .net domains, as well as a suite of domain name services, including domain name registration, transfers, renewals, expiration protection, and privacy services. The company also offers Do-It-For-Me Web solutions, including Custom Websites with built in marketing, analytics, and hosting facilities; Ignite that enables Websites to be promoted in various directories; Facebook Boost by Web.com, which designs or updates the business profile page on Facebook and includes monthly advertising and postings; and eCommerce that designs, setups, and configures the online store and shopping cart. In addition, it provides Do-It-Yourself Web solutions, such as Website building and marketing solutions, such as hosting services; Website building tools for users to customize their design; eCommerce tool that help businesses begin to sell from their Website; and email services comprising email accounts, storage, spam and virus protection, Webmail, and document sharing. Further, the company offers online marketing services, including search engine optimization; local and national search engine marketing services; Leads by Web; lead generation services to contractors, homebuilders, and remodeling professionals; and online advertising services. Web.com Group, Inc. markets its products and services through online channels, outbound and inbound telesales, television and radio advertising campaigns, local direct sales, and branding, as well as through resellers, affiliate networks, and private label partners. The company was incorporated in 1999 and is headquartered in Jacksonville, Florida.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Webchain (CURRENCY:WEB) traded down 5.5% against the U.S. dollar during the twenty-four hour period ending at 18:00 PM Eastern on February 16th. Over the last seven days, Webchain has traded 2.3% higher against the U.S. dollar. Webchain has a market capitalization of $111,477.00 and $567.00 worth of Webchain was traded on exchanges in the last 24 hours. One Webchain coin can now be purchased for $0.0013 or 0.00000037 BTC on exchanges including ChaoEX , STEX, RaisEX and Coinroom.

  • [By Stephan Byrd]

    Webcoin (CURRENCY:WEB) traded 0.1% lower against the U.S. dollar during the twenty-four hour period ending at 18:00 PM E.T. on February 3rd. During the last week, Webcoin has traded up 6.5% against the U.S. dollar. Webcoin has a market cap of $144,028.00 and $928,933.00 worth of Webcoin was traded on exchanges in the last 24 hours. One Webcoin coin can currently be bought for $0.0042 or 0.00000123 BTC on major exchanges including $51.55, $5.60, $20.33 and $13.77.

  • [By Daniel Sparks]

    Online marketing solutions company Web.com(NASDAQ:WEB) saw its stock jump as much as 12.1% on Thursday. The stock finished the trading day up 11.4%.

  • [By Anders Bylund]

    Shares of Web.com Group (NASDAQ:WEB) soared as much as 13.5% higher in Monday’s trading session, following the disclosure of an activist investor taking a larger financial interest in the company. By 3:30 p.m. EDT, the stock had settled down at a milder 11.2% gain.

Hot Low Price Stocks To Watch Right Now: Catalent, Inc.(CTLT)

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products worldwide. It operates through three segments: Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segments oral dose forms include soft gel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development & Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. The company serves large pharmaceutical and biotechnology companies; mid-size, emerging, and specialty pharmaceutical and biotechnology companies; and consumer health companies, as well as companies in other healthcare market segments, such as animal health and medical devices and companies in industries, including cosmetics. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Catalent (CTLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Catalent (CTLT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Low Price Stocks To Watch Right Now: Newmont Mining Corporation(NEM)

Newmont Mining Corporation, together with its subsidiaries, operates in the mining industry. It primarily acquires, develops, explores for, and produces gold, silver, and copper. The companys operations and/or assets are located in the United States, Australia, Peru, Indonesia, Ghana, and Suriname. As of December 31, 2015, it had proven and probable gold reserves of 73.7 million ounces and an aggregate land position of approximately 20,000 square miles. The company was founded in 1916 and is headquartered in Greenwood Village, Colorado.

Advisors’ Opinion:

  • [By Neha Chamaria]

    In fact, there couldn’t be a better time to buy gold stocks, given the ongoing industry consolidation. Two massive recent deals — Barrick Gold’s (NYSE:GOLD) merger with Randgold Resources and Newmont Mining’s (NYSE:NEM) impending acquisition of Goldcorp (NYSE:GG) — are creating the world’s two largest publicly traded gold mining companies. More recently, Barrick Gold even made a takeover bid for Newmont Mining, but the two gold mining giants have only agreed to combine their operations in Nevada in a joint venture as of this writing. These developments make investing in gold stocks now incredibly interesting.

  • [By Chris Hill]

    It’s not every day that mining companies make the news here, and that’s because investors are often better off ignoring them. But Barrick Gold(NYSE:GOLD) and Newmont Mining(NYSE:NEM) have been tying up in a big way, creating something to the tune of a $30 billion joint venture in the gold space.

  • [By Shane Hupp]

    Newmont Mining (NYSE:NEM) has been given a $47.00 target price by equities researchers at Raymond James in a research note issued to investors on Tuesday. The brokerage presently has an “outperform” rating on the basic materials company’s stock. Raymond James’ target price would suggest a potential upside of 36.83% from the company’s current price.

  • [By Paul Ausick]

    Just a week ago today, Barrick Gold Corp. (NYSE: GOLD) announced an unsolicited offer to acquire rival miner Newmont Mining Corp. (NYSE: NEM) for $18 billion. The all-stock offer was rejected Monday morning by Newmont’s board of directors in a decision that was entirely predictable. Less predictable, perhaps, was Newmont’s counteroffer of a joint venture between the two firms’ Nevada operations.

Top 5 Blue Chip Stocks To Watch Right Now

Leave a reply

Equities analysts predict that Re/Max Holdings Inc (NYSE:RMAX) will post earnings per share of $0.42 for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Re/Max’s earnings. Re/Max reported earnings of $0.49 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 14.3%. The firm is scheduled to issue its next earnings results on Thursday, May 2nd.

On average, analysts expect that Re/Max will report full year earnings of $2.07 per share for the current financial year. For the next fiscal year, analysts forecast that the company will post earnings of $2.27 per share. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side analysts that follow Re/Max.

Top 5 Blue Chip Stocks To Watch Right Now: Bayer Aktiengesellschaft (BAYRY)

Bayer AG is a life science company. The Company’s segments are Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment is engaged in the development of prescription pharmaceuticals; contraceptives, and medical products, such as injection systems and contrast agents for diagnostic procedures. The Consumer Health segment is engaged in the development of over-the-counter medications, dermatology products and nutritional supplements. The Crop Science segment is engaged in the development of product portfolio in the areas of seeds and plant traits, crop protection, home and garden, the green industry and nonagricultural pest control. The Animal Health segment is engaged in the development of veterinary medicines and animal grooming products. Covestro is engaged in the development of raw materials for polyurethanes; polycarbonate resins and sheets; raw materials for coatings, adhesives and sealants; and selected chemical intermediates.
Advisors’ Opinion:

  • [By ]

    Bayer (OTCPK:BAYRY) – Together with Orion Corporation, the company announced that the FDA accepted its New Drug Application and granted Priority Review for darolutamide for the treatment of non-metastatic castration-resistant prostate cancer in the United States. This decision was based on data from the phase III ARAMIS trial – recently, Bayer also submitted an application to the European Medicines Agency and the Ministry of Health, Labor and Welfare in Japan. The drug candidate is thought to have peak sales potential in excess of $1 billion.

  • [By ]

    Overall, investors need to rely on what is factual and can be referenced. FOTIVDA still outperforms Bayers (OTCPK:BAYRY) Nexavar in PFS and ORR. The preliminary OS data is not complete enough for the FDA and that should be acceptable for investors. In fact, the idea the company had not really addressed the issues from the previous CRL would have prevented me from entering a position prior to the PDUFA date. The market overreacted to the NDA delay news as if it was a CRL. Yes, the company has to hold off on submitting, but the management expects to file an NDA before the end of 2019; which would put the PDUFA date in the second half of 2020.

  • [By Cory Renauer]

    The first to earn approval, Vitrakvi, treats patients with any type of cancer, as long as their tumors test positive for a specific mutation. Bayer (NASDAQOTH:BAYRY) will market Vitrakvi and send Lilly royalties in a low-30s percentage range on U.S. sales and a tiered double-digit percentage of sales everywhere else.

  • [By Todd Campbell]

    In the second quarter, Eylea’s net product sales in the U.S. alone were $992 million, up from $919 million last year. Regeneron pocketed $263 million in profit on Eylea’s sales outside the U.S. last quarter, where Bayer AG (NASDAQOTH:BAYRY)markets it. Ex-U.S. revenue reported on Bayer sales in Q2 2017 was $204 million. Overall, Eylea’s global sales totaled $1.66 billion in Q2, giving the drug an annualized sales run rate above $5.2 billion worldwide.

Top 5 Blue Chip Stocks To Watch Right Now: Newmont Mining Corporation(NEM)

Newmont Mining Corporation, together with its subsidiaries, operates in the mining industry. It primarily acquires, develops, explores for, and produces gold, silver, and copper. The companys operations and/or assets are located in the United States, Australia, Peru, Indonesia, Ghana, and Suriname. As of December 31, 2015, it had proven and probable gold reserves of 73.7 million ounces and an aggregate land position of approximately 20,000 square miles. The company was founded in 1916 and is headquartered in Greenwood Village, Colorado.

Advisors’ Opinion:

  • [By Neha Chamaria]

    In fact, there couldn’t be a better time to buy gold stocks, given the ongoing industry consolidation. Two massive recent deals — Barrick Gold’s (NYSE:GOLD) merger with Randgold Resources and Newmont Mining’s (NYSE:NEM) impending acquisition of Goldcorp (NYSE:GG) — are creating the world’s two largest publicly traded gold mining companies. More recently, Barrick Gold even made a takeover bid for Newmont Mining, but the two gold mining giants have only agreed to combine their operations in Nevada in a joint venture as of this writing. These developments make investing in gold stocks now incredibly interesting.

  • [By Chris Hill]

    It’s not every day that mining companies make the news here, and that’s because investors are often better off ignoring them. But Barrick Gold(NYSE:GOLD) and Newmont Mining(NYSE:NEM) have been tying up in a big way, creating something to the tune of a $30 billion joint venture in the gold space.

  • [By Shane Hupp]

    Newmont Mining (NYSE:NEM) has been given a $47.00 target price by equities researchers at Raymond James in a research note issued to investors on Tuesday. The brokerage presently has an “outperform” rating on the basic materials company’s stock. Raymond James’ target price would suggest a potential upside of 36.83% from the company’s current price.

Top 5 Blue Chip Stocks To Watch Right Now: Markel Corporation(MKL)

Markel Corporation markets and underwrites specialty insurance products in the United States and internationally. It operates through three segments: U.S. Insurance, International Insurance, and Reinsurance. The U.S. Insurance segment writes general liability, professional liability, property, personal line, program, workers’ compensation, and other insurance product lines. The International Insurance segment provides professional liability, marine and energy, general liability, property, and other insurance product lines, such as accident and health coverage insurance. The Reinsurance segment offers various treaty reinsurance products, such as property, casualty, auto, and others. Markel Corporation was founded in 1930 and is headquartered in Glen Allen, Virginia.

Advisors’ Opinion:

  • [By Jordan Wathen, Matthew Frankel, CFP, and Dan Caplinger]

    Below, three Motley Fool contributors make the case for three different insurers with very different business models: Markel (NYSE:MKL), Chubb (NYSE:CB), and First American Financial (NYSE:FAF).

  • [By Motley Fool Transcribing]

    Markel (NYSE:MKL) Q4 2018 Earnings Conference CallFeb. 6, 2019 9:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Steve Symington]

    Markel(NYSE:MKL)announced fourth-quarter and full-year 2018 results on Tuesday after the market closed. The diversified insurance and financial holding company detailed seemingly steep losses, albeit driven by a combination of one-time writedowns and new accounting standards that track the fair value of its equity portfolio.

  • [By Matthew Frankel, CFP]

    Moser: We’re looking forward to that. I’m going to go, on that same wavelength there, our little baby Berkshire that we always call it, Markel (NYSE:MKL), ticker MKL, earnings are coming out on Tuesday. Not a lot that goes on with this business on a quarter-to-quarter basis. It’s pretty consistent. You’ve got the insurance business, you’ve got the Markel Venture side of things. They’ve got their investment portfolio, much like Berkshire Hathaway has. Listeners will recall that there was a little bit of an issue here. They announced there was an investigation into the reinsurance side of the business, specifically it was in regard to reserves. Looking for any clarity on that, and how it could play out on the business here for the coming year. It’s a reserve issue, it doesn’t sound like it’s anything very pivotal to the overall company. But, hey, maybe it plays out on the book value of the company in the short run, and maybe that offers investors an opportunity if there’s a little dip in the stock. This has been one that we’ve owned for long periods of time here in a number of our services here at The Fool, and I suspect that will remain the case regardless of what they say with the earnings release. But hey, if the stock takes a dive, investors may want to take a look at it because it’s still a very good business.

Top 5 Blue Chip Stocks To Watch Right Now: Littelfuse Inc.(LFUS)

Littelfuse, Inc. designs, manufactures, and sells circuit protection devices for use in the automotive, electronic, and electrical markets in the Americas, Europe, and the Asia-Pacific. The company offers electronic circuit protection products, such as fuses and protectors, positive temperature coefficient resettable fuses, varistors, polymer electrostatic discharge suppressors, discrete transient voltage suppression diodes, TVS diode arrays and protection thyristors, gas discharge tubes, and power switching components, as well as fuseholders, blocks, and related accessories under PICO II, and NANO2 SMF, TECCOR, SIDACtor, and Battrax brand names. It offers its electronic circuit protection products for use in wireless telephones, consumer electronics, computers, modems, telecommunications equipment, telephones, data transmission lines, and alarm systems. The company also provides automotive fuses that are used in automobiles, trucks, buses, and off-road equipment to protec t electrical circuits and the wires that supply electrical power to operate lights, heating, air conditioning, radios, windows, and other controls, as well as offers fuses for the protection of electric and hybrid vehicles. It markets its automotive fuse products under ATO, MINI, MAXI, MIDI, MEGA, MasterFuse, JCASE, and CablePro brand names. In addition, Littelfuse manufactures various low-voltage and medium-voltage circuit protection products, such as power fuses that are used in the protection from over-load and short-circuit currents in motor branch circuits, heating and cooling systems, control systems, lighting circuits, and electrical distribution networks to electrical distributors and their customers in the construction, original equipment manufacturers, and industrial maintenance and repair and operating supplies markets. Littelfuse sells its products through direct sales force and manufacturers? representatives. The company was founded in 1927 and is headquartered in Chicago, Illinois.

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Littelfuse (LFUS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Littelfuse, Inc. (NASDAQ:LFUS) – Research analysts at Barrington Research reduced their Q3 2019 earnings estimates for Littelfuse in a research note issued to investors on Thursday, January 31st. Barrington Research analyst G. Prestopino now forecasts that the technology company will post earnings per share of $2.76 for the quarter, down from their prior forecast of $2.81. Barrington Research has a “Hold” rating on the stock. Barrington Research also issued estimates for Littelfuse’s Q4 2019 earnings at $2.35 EPS, Q2 2020 earnings at $2.91 EPS and FY2020 earnings at $10.63 EPS.

Top 5 Blue Chip Stocks To Watch Right Now: SuperCom, Ltd.(SPCB)

SuperCom Ltd. provides traditional and digital identity solutions to governments, and private and public organizations worldwide. The company offers real-time positioning, tracking, monitoring, and verification solutions enabled by its PureRF wireless hybrid suite of products and technologies that are connected to a Web-based interactive interface. Its PureRF suite is a location position system solution based on active radio frequency identification (RFID) tag technology that enables commercial customers and governmental agencies to identify, locate, track, monitor, count, and protect people and objects. The companys PureRF suite provides various product components, such as PureRF tags, hands-free long-range RFID asset tags, hands-free long-range RFID vehicle tags, PureRF readers, PureRF activators, and PureRF Initializer. In addition, it provides house arrest monitoring systems, GPS offender tracking systems, PureMonitor offender electronic monitoring software, inmate monitoring systems, and domestic violence victim protection systems. Further, the company offers national identification registries, e-passports, biometric visas, automated fingerprint identification systems, digitized drivers licenses, and electronic voter registration and election management through the companys MAGNA common platform to the law enforcement agencies, community safety agencies, and the ministries of justice. Additionally, it provides SuperPay, a secure mobile payment hybrid suite; PureMoney Suite that provides mobile money applications and services; and SuperPOS, a platform to perform mobile payments. It sells its systems and products through local representatives, subsidiaries, resellers, and distribution channels that include direct sales and sales through traditional distributors or resellers. The company was formerly known as Vuance Ltd. and changed its name to SuperCom Ltd. in January 2013. SuperCom Ltd. was founded in 1988 and is headquartered in Herzliya, Israel.

Advisors’ Opinion:

  • [By Stephan Byrd]

    SuperCom (NASDAQ:SPCB) and CEVA (NASDAQ:CEVA) are both small-cap industrial products companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, dividends, profitability, valuation, risk and analyst recommendations.

  • [By Alexander Bird]

    Here are the top performers from last week…

    Penny Stock Current Share Price Last Week’s Gain
    Aegean Marine Petroleum Network Inc. (NYSE: ANW) $1.83 165.71%
    Radisys Corp. (Nasdaq: RSYS) $1.55 115.68%
    Ascent Capital Group Inc. (Nasdaq: ASCMA) $3.71 43.12%
    Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) $4.36 40.63%
    Tintri Inc. (Nasdaq: TNTR) $0.18 40.49%
    Prana Biotechnology Ltd. (Nasdaq: PRAN) $2.35 39.96%
    Micronet Enertec Technologies Inc. (Nasdaq: MICT) $1.60 39.40%
    Corindus Vascular Robotics (NYSE: CVRS) $1.17 34.40%
    ParkerVision Inc. (Nasdaq: PRKR) $0.70 30.65%
    SuperCom Ltd. (Nasdaq: SPCB) $0.24 30.10%

    While these gains are exciting, they pale in comparison to the profit potential of our top penny stock to buy this week.

Best Gold Stocks To Buy For 2019

Leave a reply

Image source: The Motley Fool.

Beazer Homes USA Inc  (NYSE:BZH)Q1 2019 Earnings Conference CallFeb. 04, 2019, 5:00 p.m. ET

Contents:
Prepared Remarks Questions and Answers Call Participants
Prepared Remarks:

Operator

Good afternoon, and welcome to the Beazer Homes Earnings Conference Call for the quarter ended December 31, 2018. Today’s call is being recorded and a replay will be available on the Company’s website later today. In addition, PowerPoint slides intended to accompany this call are available in the Investor Relations section of the Company’s website at www.beazer.com.

At this point, I will turn the call over to David Goldberg, Vice President and Treasurer.

David I. Goldberg — Vice President & Treasurer

Thank you. Good afternoon, and welcome to the Beazer Homes conference call discussing our results for the first quarter of fiscal 2019. Before we begin, you should be aware that during this call, we’ll be making forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors, which are described in our SEC filings, including our Form 10-K, which may cause actual results to differ materially from our projections. Any forward-looking statement speaks only as of the date the statement is made, and we do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. New factors emerge from time-to-time, and it’s simply not possible to predict all such factors.

Best Gold Stocks To Buy For 2019: MEDIFAST INC(MED)

Advisors’ Opinion:

  • [By Lisa Levin]

    Medifast, Inc. (NYSE: MED) shares were also up, gaining 25 percent to $124.60 after the company reported strong Q1 results and raised its FY18 guidance.

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings.
    Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share.
    California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings.
    Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results.
    Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter.
    Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results.
    Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results.
    B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings.
    HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
  • [By Logan Wallace]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. MediBloc [QRC20]’s official website is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The official message board for MediBloc [QRC20] is medium.com/@MediBloc. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here.

  • [By Max Byerly]

    MediBloc [QRC20] (MED) is a proof-of-work (PoW) token that uses the HybridScryptHash256 hashing algorithm. It was first traded on January 3rd, 2014. MediBloc [QRC20]’s total supply is 4,097,545,844 tokens and its circulating supply is 2,966,384,100 tokens. The official website for MediBloc [QRC20] is medibloc.org/en. MediBloc [QRC20]’s official Twitter account is @MEDDevTeam. The Reddit community for MediBloc [QRC20] is /r/MediBloc and the currency’s Github account can be viewed here. MediBloc [QRC20]’s official message board is medium.com/@MediBloc.

  • [By Ethan Ryder]

    MediBloc [MED] (CURRENCY:MED) traded down 11.7% against the U.S. dollar during the 1 day period ending at 21:00 PM Eastern on September 2nd. One MediBloc [MED] token can now be bought for approximately $0.0066 or 0.00000100 BTC on popular cryptocurrency exchanges including Coinrail, Bibox and Gate.io. During the last week, MediBloc [MED] has traded down 27.6% against the U.S. dollar. MediBloc [MED] has a total market cap of $19.63 million and approximately $281,103.00 worth of MediBloc [MED] was traded on exchanges in the last 24 hours.

Best Gold Stocks To Buy For 2019: Castle (A.M.) & Co.(CAS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cashaa (CURRENCY:CAS) traded up 3% against the US dollar during the 1 day period ending at 23:00 PM E.T. on September 18th. During the last seven days, Cashaa has traded 2.5% lower against the US dollar. Cashaa has a market capitalization of $6.33 million and $110,922.00 worth of Cashaa was traded on exchanges in the last day. One Cashaa token can currently be purchased for approximately $0.0124 or 0.00000195 BTC on popular cryptocurrency exchanges including Exrates, TOPBTC, IDEX and HitBTC.

  • [By Joseph Griffin]

    Cascades Inc (TSE:CAS) – Analysts at National Bank Financial raised their Q4 2018 earnings per share (EPS) estimates for Cascades in a report issued on Thursday, August 9th. National Bank Financial analyst L. Aghazarian now expects that the company will post earnings of $0.28 per share for the quarter, up from their previous estimate of $0.26. National Bank Financial has a “Outperform” rating and a $18.00 price target on the stock.

  • [By Max Byerly]

    Cashaa (CURRENCY:CAS) traded 5.4% lower against the U.S. dollar during the 1-day period ending at 17:00 PM Eastern on June 26th. Cashaa has a total market capitalization of $14.70 million and $413,446.00 worth of Cashaa was traded on exchanges in the last 24 hours. One Cashaa token can now be bought for approximately $0.0354 or 0.00000572 BTC on popular exchanges including HitBTC and IDEX. During the last week, Cashaa has traded down 17.6% against the U.S. dollar.

Best Gold Stocks To Buy For 2019: Newmont Mining Corporation(NEM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Newmont Mining Corp. (NYSE: NEM) dropped about 0.5% Friday to set a new 52-week low of $31.45. Shares closed at $31.60 on Thursday and the stock’s 52-week high is $42.04. Volume totaled around 6.7 million, about 50% above the daily average. The company had no specific news.

  • [By Shane Hupp]

    Newmont Mining (NYSE:NEM) was downgraded by analysts at Zacks Investment Research from a hold rating to a strong sell rating. According to Zacks, “Estimates for Newmont for the third quarter and full year have gone down lately. Newmont faces headwinds from high production costs. The company’s all-in sustaining costs rose year over year in the second quarter, mainly due to higher per unit costs applicable to sales, exploration costs and increased spending on advanced projects. The company is also exposed to a highly volatile gold price environment. Lack of growth in the company’s gold reserves is another concern. Moreover, the company’s shares have underperformed the industry it belongs to, in the past six months.”

  • [By Shane Hupp]

    Newmont Mining Corp (NYSE:NEM) EVP Elaine J. Dorward-King sold 3,000 shares of the firm’s stock in a transaction that occurred on Monday, July 2nd. The stock was sold at an average price of $37.47, for a total value of $112,410.00. Following the sale, the executive vice president now directly owns 111,831 shares of the company’s stock, valued at $4,190,307.57. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

  • [By Joseph Griffin]

    Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    Fortuna Silver Mines (NYSE: FSM) and Newmont Mining (NYSE:NEM) are both basic materials companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, dividends, valuation and profitability.

  • [By Trey Thoelcke]

    Newmont Mining Corp. (NYSE: NEM) is scheduled to report its fourth-quarter results before Thursday’s open. The consensus estimates call for EPS of $0.25 and $1.88 billion in revenue. Shares closed at $33.24 on Friday. The consensus price target is $40.00, and the 52-week trading range is $29.06 to $41.98.

Best Heal Care Stocks To Watch For 2019

Leave a reply

Northwestern Mutual Investment Management Company LLC lessened its stake in Noble Energy, Inc. (NYSE:NBL) by 18.5% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 89,589 shares of the oil and gas development company’s stock after selling 20,322 shares during the quarter. Northwestern Mutual Investment Management Company LLC’s holdings in Noble Energy were worth $2,715,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of NBL. Artisan Partners Limited Partnership lifted its holdings in shares of Noble Energy by 95.1% in the first quarter. Artisan Partners Limited Partnership now owns 15,854,643 shares of the oil and gas development company’s stock valued at $480,396,000 after purchasing an additional 7,730,137 shares in the last quarter. Ceredex Value Advisors LLC bought a new position in shares of Noble Energy in the first quarter valued at approximately $65,880,000. Amundi Pioneer Asset Management Inc. bought a new position in shares of Noble Energy in the fourth quarter valued at approximately $29,414,000. Sei Investments Co. lifted its holdings in shares of Noble Energy by 53.7% in the first quarter. Sei Investments Co. now owns 2,544,673 shares of the oil and gas development company’s stock valued at $77,103,000 after purchasing an additional 888,576 shares in the last quarter. Finally, Alliancebernstein L.P. lifted its holdings in shares of Noble Energy by 22.4% in the fourth quarter. Alliancebernstein L.P. now owns 3,984,847 shares of the oil and gas development company’s stock valued at $116,118,000 after purchasing an additional 728,937 shares in the last quarter. Institutional investors own 98.58% of the company’s stock.

Best Heal Care Stocks To Watch For 2019: Newmont Mining Corporation(NEM)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Barrick isn’t the only major miner that’s been focused on debt reduction. But it has been beating peers like Newmont Mining (NYSE:NEM), Kinross Gold (NYSE:KGC), and Goldcorp (NYSE:GG) on this front, in some cases by a very wide margin. Barrick estimates that the massive balance-sheet effort has saved it around $300 million a year in interest expenses. Long-term debt is now back down to around 30% of the miner’s capital structure.   

  • [By Jon C. Ogg]

    Newmont Mining Corp. (NYSE: NEM) was trading at $32.20, with a market value of $17 billion and a 52-week range of $31.45 to $42.05. The consensus target price of $44.16 is not even 1% lower than just 90 days earlier. If the analyst community’s continued bullish calls prove true, that’s a projected 37% upside.

  • [By Todd Campbell]

    If these reasons have you interested in adding gold mining stocks to your portfolio, a few top companies to consider are Barrick Gold (NYSE:ABX), Randgold Resources (NASDAQ:GOLD), Newmont Mining (NYSE:NEM), Freeport McMoran (NYSE:FCX) and Goldcorp (NYSE:GG). All five could benefit if gold prices rally, so let’s learn more about them.

  • [By Rich Smith]

    Investors in gold stocks are experiencing an up-down day today, as shares of Newmont Mining (NYSE:NEM) surge — and those of Barrick Gold (NYSE:ABX) fall back. For this, you can thank the analysts at Morgan Stanley, who chose today to upgrade the former and downgrade the latter.

Best Heal Care Stocks To Watch For 2019: Smith(ds)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Drive Shack Inc (NYSE:DS)’s share price hit a new 52-week high and low during trading on Thursday . The company traded as low as $7.18 and last traded at $6.91, with a volume of 21368 shares trading hands. The stock had previously closed at $7.04.

  • [By Logan Wallace]

    Redwood Trust (NYSE: RWT) and Drive Shack (NYSE:DS) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, profitability, earnings, institutional ownership, valuation, dividends and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Drive Shack (DS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Best Heal Care Stocks To Watch For 2019: Nexstar Broadcasting Group Inc.(NXST)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Nexstar Media Group Inc (NASDAQ:NXST) insider Andrew Alford sold 150 shares of the company’s stock in a transaction on Monday, August 20th. The shares were sold at an average price of $79.71, for a total transaction of $11,956.50. Following the transaction, the insider now owns 1,520 shares of the company’s stock, valued at $121,159.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

  • [By Ethan Ryder]

    These are some of the headlines that may have impacted Accern Sentiment’s scoring:

    Get Nexstar Media Group alerts:

    Nexstar Media Group Inc (NXST) Given Consensus Rating of “Buy” by Analysts (americanbankingnews.com) Nexstar Media Group Inc (NXST) Insider Sells $11,956.50 in Stock (americanbankingnews.com) Nexstar Media Group (NXST) Cut to “Hold” at Noble Financial (americanbankingnews.com) Nexstar Media Group Inc to Post Q3 2018 Earnings of $1.94 Per Share, Barrington Research Forecasts (NXST) (americanbankingnews.com) Get Active Home Medical and Mobility (wdtn.com)

    Shares of NXST opened at $81.40 on Thursday. Nexstar Media Group has a 52-week low of $56.65 and a 52-week high of $89.75. The company has a debt-to-equity ratio of 2.59, a quick ratio of 2.43 and a current ratio of 2.43. The firm has a market capitalization of $3.57 billion, a PE ratio of 20.45, a price-to-earnings-growth ratio of 1.61 and a beta of 1.88.

  • [By Stephan Byrd]

    Nexstar Media Group (NASDAQ: NXST) and Liberty Media Formula One Series C (NASDAQ:FWONK) are both mid-cap consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk.

Best Heal Care Stocks To Watch For 2019: Golden Ocean Group Limited(GOGL)

Advisors’ Opinion:

  • [By Max Byerly]

    Golden Ocean Group (NASDAQ:GOGL) last released its quarterly earnings results on Friday, August 17th. The shipping company reported $0.07 EPS for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. Golden Ocean Group had a net margin of 9.34% and a return on equity of 3.71%. The business had revenue of $140.89 million for the quarter, compared to analyst estimates of $98.87 million. sell-side analysts anticipate that Golden Ocean Group Ltd will post 0.49 EPS for the current year.

  • [By Ethan Ryder]

    Jane Street Group LLC raised its holdings in shares of Golden Ocean Group Ltd (NASDAQ:GOGL) by 99.4% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 224,567 shares of the shipping company’s stock after purchasing an additional 111,971 shares during the period. Jane Street Group LLC owned approximately 0.16% of Golden Ocean Group worth $1,785,000 at the end of the most recent quarter.

  • [By Lisa Levin] Gainers
    Pacific Biosciences of California, Inc. (NASDAQ: PACB) rose 11.4 percent to $2.93 in pre-market trading.
    Check-Cap Ltd. (NASDAQ: CHEK) shares rose 6.3 percent to $4.76 in pre-market trading as the company announced the publication of CE Mark multicenter clinical study results on C-Scan® in Gut.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 6 percent to $ 35.20 in pre-market trading.
    Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 6 percent to $7.60 in pre-market trading.
    Hexindai Inc. (NASDAQ: HX) rose 5.7 percent to $12.70 in pre-market trading.
    MoSys, Inc. (NASDAQ: MOSY) shares rose 5.3 percent to $2.07 in pre-market trading.
    Micron Technology, Inc. (NASDAQ: MU) rose 5 percent to $58.20 in pre-market trading after reporting a $10 billion buyback plan.
    Golden Ocean Group Limited (NASDAQ: GOGL) rose 4.1 percent to $8.63 in pre-market trading.
    MorphoSys AG (NASDAQ: MOR) rose 3.5 percent to $26.99 in pre-market trading.
    Cyren Ltd (NASDAQ: CYRN) shares rose 3.4 percent to $2.90 in pre-market trading. after reporting Q1 results.
    Box, Inc. (NYSE: BOX) rose 3.4 percent to $28.76 in pre-market trading.
    Kohl's Corporation (NYSE: KSS) shares rose 3.3 percent to $67.60 in the pre-market trading session after the company reported upbeat quarterly earnings.
    Micro Focus International plc (NYSE: MFGP) shares rose 3.1 percent to $18.40 in pre-market trading.

     

  • [By Motley Fool Staff]

    Golden Ocean Group (NASDAQ:GOGL) Q1 2018 Earnings Conference CallMay. 30, 2018 9:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    Teekay Offshore Partners (NYSE: TOO) and Golden Ocean Group (NASDAQ:GOGL) are both small-cap transportation companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk.

  • [By Lisa Levin] Gainers
    Sanmina Corp (NASDAQ: SANM) shares rose 15.2 percent to $31.90 in pre-market trading as the company reported stronger-than-expected earnings for its second quarter on Monday.
    Cadence Design Systems, Inc. (NASDAQ: CDNS) rose 12.4 percent to $41.30 in pre-market trading after the company posted upbeat Q1 results and issued a strong Q2 forecast.
    Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) rose 10.8 percent to $8.75 in pre-market trading.
    Mitel Networks Corporation (NASDAQ: MITL) rose 8.8 percent to $11.05 in pre-market trading after the company agreed to be acquired by affiliates of Searchlight Capital Partners for $2.0 billion.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) rose 7.3 percent to $3.70 in pre-market trading.
    Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 6.9 percent to $7.00 in pre-market trading after declining 1.50 percent on Monday.
    Hallmark Financial Services, Inc. (NASDAQ: HALL) rose 6.5 percent to $10.68 in pre-market trading.
    Boot Barn Holdings, Inc. (NYSE: BOOT) rose 5.2 percent to $20.40 in pre-market trading after gaining 4.53 percent on Monday.
    New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5 percent to $91.16 in pre-market trading after reporting Q3 results.
    Shire plc (NASDAQ: SHPG) rose 5 percent to $167.98 in pre-market trading after Bloomberg reported that Takeda is nearing a preliminary agreement to acquire Shire after sweetened bid.
    Outfront Media Inc. (NYSE: OUT) shares rose 5 percent to $19.00 in pre-market trading.
    Geron Corporation (NASDAQ: GERN) rose 4.3 percent to $4.18 in pre-market trading after gaining 5.80 percent on Monday.
    SAP SE (NYSE: SAP) rose 3.7 percent to $109.80 in pre-market trading after the company posted strong quarterly results and raised its outlook for the year.
    Golden Ocean Group Limited (NASDAQ: GOGL) shares rose 3.7 percent to $8.70 in pre-market trading after gaining 1.45 percent on Monday.
    Deutsche Bank Aktiengesellschaft (NYSE: D

Hot Medical Stocks To Own For 2019

Leave a reply

Heska (NASDAQ:HSKA)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity in a research report issued to clients and investors on Friday, MarketBeat reports. They presently have a $115.00 price objective on the medical research company’s stock, up from their prior price objective of $100.00. Canaccord Genuity’s price objective would indicate a potential upside of 12.52% from the company’s previous close.

Several other analysts also recently commented on the company. B. Riley increased their price objective on Heska from $77.00 to $93.00 and gave the stock a “neutral” rating in a research note on Friday. BidaskClub raised Heska from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, May 8th. Benchmark increased their price objective on Heska from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 7th. ValuEngine raised Heska from a “sell” rating to a “hold” rating in a research note on Friday, May 4th. Finally, Zacks Investment Research raised Heska from a “sell” rating to a “hold” rating in a research note on Thursday, May 3rd. Three investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $106.75.

Hot Medical Stocks To Own For 2019: Cemex S.A.B. de C.V.(CX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Fisher Asset Management LLC cut its holdings in shares of Cemex (NYSE:CX) by 6.3% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,573,830 shares of the construction company’s stock after selling 505,100 shares during the period. Fisher Asset Management LLC owned 0.52% of Cemex worth $50,139,000 as of its most recent SEC filing.

  • [By ]

    Cemex (NYSE: CX) is a global building materials company that produces, distributes and sells cement, ready-mix concrete, aggregates and related building materials in more than 50 countries. Cemex’s U.S. network includes 11 cement plants, 43 strategically located distribution terminals, 57 aggregate quarries and more than 270 ready-mix concrete plants. Its products are used in bridges, roads, structures, dams and more.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) traded down about 2% Friday to post a new 52-week low of $5.72 after closing Thursday at $5.84. The stock’s 52-week high is $10.37. Volume was about 10% above the daily average of around 9.3 million shares. The company had no specific news.

  • [By Jon C. Ogg]

    CEMEX SAB de C.V. (NYSE: CX) has had a rough year, with much of the ongoing trade war risks putting Mexico at risk due to NAFTA being renegotiated by the White House. There are even risks that NAFTA could be canceled. That would be bad news for a company like Cemex, with its large cement operations. Cemex is the third largest cement company in the world, based on its installed capacity, and it is considered to be the largest concrete company in the world.

  • [By Paul Ausick]

    Cemex SAB de CV (NYSE: CX) traded down 4% Tuesday and posted a new 52-week low of $6.68 after closing Monday at $6.96. The stock’s 52-week high is $10.37. Volume was around 12.5 million, about 25% above the daily average of around 10.5 million. The company had no specific news.

Hot Medical Stocks To Own For 2019: Newmont Mining Corporation(NEM)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Boston Partners boosted its holdings in shares of Newmont Mining Co. (NYSE:NEM) by 4.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 50,976 shares of the basic materials company’s stock after buying an additional 2,033 shares during the quarter. Boston Partners’ holdings in Newmont Mining were worth $1,992,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    Wilkins Investment Counsel Inc. lifted its stake in Newmont Mining Co. (NYSE:NEM) by 0.7% in the 1st quarter, Holdings Channel reports. The firm owned 359,285 shares of the basic materials company’s stock after acquiring an additional 2,550 shares during the period. Newmont Mining comprises about 4.4% of Wilkins Investment Counsel Inc.’s holdings, making the stock its 2nd biggest position. Wilkins Investment Counsel Inc.’s holdings in Newmont Mining were worth $14,037,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Engineers Gate Manager LP lessened its stake in shares of Newmont Mining Co. (NYSE:NEM) by 44.6% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 85,506 shares of the basic materials company’s stock after selling 68,807 shares during the period. Engineers Gate Manager LP’s holdings in Newmont Mining were worth $3,341,000 at the end of the most recent reporting period.

  • [By Matthew DiLallo]

    Barrick Gold is the largest gold miner in the world, producing 5.32 million ounces of the precious metal in 2017. While that was down from 5.53 million ounces in 2016 — and well off the company’s peak from a few years ago — it was enough to edge out Newmont Mining’s (NYSE:NEM) 5.27 million ounces for the top spot. In addition to gold, Barrick also produced 413 million pounds of copper, which — while significant — pales in comparison to Freeport-McMoRan’s 3.7 billion pounds, enough to make it the world’s largest publicly traded copper producer.

  • [By ]

    Gold miners have fought for their survival over the last several years, cutting new investments in production and trimming costs. Data from Bloomberg shows the average extraction costs at the largest miners has fallen 27% over the last five years. Tom Brady, Chief Economist at Newmont Mining (NYSE: NEM) estimates global gold production will slip by 1% annually over the next several years due to decreased capital spending by miners.

  • [By Logan Wallace]

    IBM Retirement Fund lessened its holdings in Newmont Mining Corp (NYSE:NEM) by 10.0% during the 1st quarter, Holdings Channel reports. The fund owned 11,778 shares of the basic materials company’s stock after selling 1,310 shares during the period. IBM Retirement Fund’s holdings in Newmont Mining were worth $460,000 at the end of the most recent quarter.

Hot Medical Stocks To Own For 2019: Scorpio Tankers Inc.(STNG)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Scorpio Tankers (STNG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rich Smith]

    Stocks don’t always make sense — a factinvestors should be happy about afterScorpio Tankers (NYSE:STNG) posted a quarterly loss and an earnings miss this morning and then rocketed 15% in early trading.

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares jumped 56.69 percent to close at $1.27 on Wednesday on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Vicor Corporation (NASDAQ: VICR) rose 26.84 percent to close at $37.10. Vicor posted Q1 earnings of $0.10 per share on sales of $65.2 million.
    AGM Group Holdings Inc. (NASDAQ: AGMH) climbed 25.56 percent to close at $10.61.
    Travelzoo (NASDAQ: TZOO) gained 24.7 percent to close at $9.75 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) shares climbed 19.24 percent to close at $4.71.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 18.73 percent to close at $18.64.
    Genprex, Inc. (NASDAQ: GNPX) climbed 18.28 percent to close at $5.89. Genprex expanded its operations to Cambridge, Mass.
    Scorpio Tankers Inc. (NYSE: STNG) rose 13.92 percent to close at $2.70 following Q1 results.
    Rocky Brands, Inc. (NASDAQ: RCKY) shares surged 13.57 percent to close at $23.85 after reporting Q1 results.
    Resonant Inc. (NASDAQ: RESN) shares rose 12.5 percent to close at $4.14 on Wednesday.
    USANA Health Sciences, Inc. (NYSE: USNA) jumped 11.24 percent to close at $106.85 following Q1 results.
    SUPERVALU Inc. (NYSE: SVU) rose 11.16 percent to close at $16.24 after the company reported Q4 results and agreed to sell and leaseback eight distribution centers for an aggregate purchase price of $483 million.
    K12 Inc. (NYSE: LRN) shares gained 10.74 percent to close at $15.36 following Q3 results.
    Tupperware Brands Corporation (NYSE: TUP) rose 9.15 percent to close at $46.28 as the company posted in-line quarterly earnings.
    Six Flags Entertainment Corporation (NYSE: SIX) shares climbed 8.49 percent to close at $64.18 as the company posted a narrower-than-expected loss for its first quarter.
    Carlisle Companies Incorporated (NYSE: CSL) gained 8.2 percent to close at $107.94 af
  • [By Max Byerly]

    Get a free copy of the Zacks research report on Scorpio Tankers (STNG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Wednesday afternoon, the energy shares gained 0.74 percent. Meanwhile, top gainers in the sector included Pengrowth Energy Corporation (NYSE: PGH), up 12 percent, and Scorpio Tankers Inc. (NYSE: STNG), up 12 percent.

Hot Medical Stocks To Own For 2019: Cedar Fair, L.P.(FUN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Cedar Fair Entertainment (NYSE: FUN) and The Madison Square Garden (NYSE:MSG) are both mid-cap consumer discretionary companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.

  • [By Jim Crumly]

    Among individual companies making news, Fastenal (NASDAQ:FAST) reported strong profits, while amusement park operator Cedar Fair (NYSE:FUN) announced a disappointing drop in early season attendance.

  • [By Brian Feroldi, Leo Sun, and Demitrios Kalogeropoulos]

    Want proof? We asked these Motley Fool investors to highlight a dividend stock that pays a higher yield than Verizon. Here’s why they pickedTanger Factory Outlets (NYSE:SKT), Cedar Fair (NYSE:FUN), andSTORE Capital (NYSE:STOR).

  • [By Steve Symington, Jeremy Bowman, and Demitrios Kalogeropoulos]

    So to help get you started, we asked three top Motley Fool investors to each pick a stock with an annual dividend yield ofat least5%. Read on to learn why they like Oaktree Capital (NYSE:OAK), Ford Motor (NYSE:F), and Cedar Fair (NYSE:FUN).

Hot Medical Stocks To Own For 2019: Farmers Capital Bank Corporation(FFKT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday morning, the financial shares climbed 0.50 percent. Meanwhile, top gainers in the sector included Farmers Capital Bank Corporation (NASDAQ: FFKT), up 16 percent, and Associated Banc-Corp (NYSE: ASB), up 9 percent.

  • [By Lisa Levin]

    On Friday, the financial shares climbed 0.31 percent. Meanwhile, top gainers in the sector included Farmers Capital Bank Corporation (NASDAQ: FFKT), up 16 percent, and Associated Banc-Corp (NYSE: ASB), up 10 percent.

  • [By Lisa Levin]

    Friday afternoon, the financial shares climbed 0.11 percent. Meanwhile, top gainers in the sector included Farmers Capital Bank Corporation (NASDAQ: FFKT), up 16 percent, and OFG Bancorp (NYSE: OFG), up 10 percent.

  • [By Lisa Levin] Gainers
    AGM Group Holdings Inc. (NASDAQ: AGMH) shares climbed 30.3 percent to $11.05 after climbing 34.60 percent on Thursday.
    Limelight Networks, Inc. (NASDAQ: LLNW) jumped 21.2 percent to $4.9699 following a first-quarter earnings beat. The company also raised its fiscal 2018 estimates.
    Telefonaktiebolaget LM Ericsson (NASDAQ: ERIC) shares climbed 18.8 percent to $7.89 after reporting strong Q1 earnings.
    Farmers Capital Bank Corp (NASDAQ: FFKT) gained 15.4 percent to $48.75. WesBanco Inc (NASDAQ: WSBC) announced an agreement and plan of merger with Farmers Capital Bank Corporation.
    TransUnion (NYSE: TRU) climbed 10.2 percent to $66.76 after the company posted upbeat Q1 results and issued a strong forecast for the second quarter. TransUnion announced plans to acquire Callcredit.
    Myomo, Inc. (NYSE: MYO) shares gained 9.2 percent to $3.9299 after rising 8.11 percent on Thursday.
    Pinnacle Foods Inc (NYSE: PF) gained 8.8 percent to $60.04 after a 13-D filing from Jana Partners showed an increased stake in the comapny, from 1.42 million shares at the end of last quarter to 10.83 million shares, or a 9.3-percent stake.
    Associated Banc-Corp (NYSE: ASB) shares climbed 8.8 percent to $26.70 following upbeat Q1 earnings.
    OFG Bancorp (NYSE: OFG) gained 8.5 percent to $12.80 after reporting Q1 results.
    Cleveland-Cliffs Inc. (NYSE: CLF) climbed 7.5 percent to $7.73 following Q1 results.
    Seaspan Corporation (NYSE: SSW) shares climbed 6.7 percent to $7.50. Deutsche Bank upgraded Seaspan from Hold to Buy.
    General Electric Company (NYSE: GE) shares rose 4.6 percent to $14.63 after the company reported better-than-expected earnings for its first quarter.
    Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) rose 4.3 percent to $47.80. Biogen and Ionis have expanded their strategic collaboration to develop drug candidates for a broad range of neurological diseases.

    Check out these big penny stock gainers and losers

Hot Medical Stocks To Own For 2019: Aceto Corporation(ACET)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get Aceto alerts:

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Aceto Corporation Investors and Set a Lead Plaintiff Deadline of June 25, 2018 – ACET (finance.yahoo.com) Every raises $600,000 to build banking platform for online businesses (betakit.com) DEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aceto Corporation and Encourages Investors with Losses in Excess of $100,000 … (businesswire.com) DEADLINE REMINDER ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Aceto Corporation and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (finance.yahoo.com) Aceto (ACET) & Trxade Group (TRXD) Head to Head Review (americanbankingnews.com)

    ACET stock traded down $0.26 during midday trading on Tuesday, reaching $3.72. 922,400 shares of the company’s stock traded hands, compared to its average volume of 675,603. Aceto has a 1-year low of $2.22 and a 1-year high of $17.10. The stock has a market capitalization of $112.07 million, a price-to-earnings ratio of 3.13 and a beta of 1.65. The company has a debt-to-equity ratio of 0.63, a current ratio of 1.12 and a quick ratio of 0.80.

  • [By Joseph Griffin]

    News coverage about Aceto (NASDAQ:ACET) has been trending somewhat negative this week, Accern Sentiment reports. Accern ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Aceto earned a news impact score of -0.08 on Accern’s scale. Accern also assigned news articles about the company an impact score of 44.4106764316888 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Lisa Levin]

    Aceto Corporation (NYSE: ACET) shares dropped 63 percent to $2.775 following announcement of financial challenges. The company has suspended further guidance and is evaluating strategic alternatives. Aceto also expects reduction in dividend moving forward. Canaccord Genuity downgraded Aceto from Buy to Sell.